These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 18619558)

  • 21. Advances in the Application of Designed Ankyrin Repeat Proteins (DARPins) as Research Tools and Protein Therapeutics.
    Boersma YL
    Methods Mol Biol; 2018; 1798():307-327. PubMed ID: 29868969
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complex and defined biostructures with the dock-and-lock method.
    Rossi EA; Goldenberg DM; Chang CH
    Trends Pharmacol Sci; 2012 Sep; 33(9):474-81. PubMed ID: 22739259
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The intracellular Ig fold: a robust protein scaffold for the engineering of molecular recognition.
    Bruning M; Barsukov I; Franke B; Barbieri S; Volk M; Leopoldseder S; Ucurum Z; Mayans O
    Protein Eng Des Sel; 2012 May; 25(5):205-12. PubMed ID: 22355150
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel protein scaffolds as emerging therapeutic proteins: from discovery to clinical proof-of-concept.
    Wurch T; Pierré A; Depil S
    Trends Biotechnol; 2012 Nov; 30(11):575-82. PubMed ID: 22944617
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibody engineering.
    Maynard J; Georgiou G
    Annu Rev Biomed Eng; 2000; 2():339-76. PubMed ID: 11701516
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Engineering of the Escherichia coli Im7 immunity protein as a loop display scaffold.
    Juraja SM; Mulhern TD; Hudson PJ; Hattarki MK; Carmichael JA; Nuttall SD
    Protein Eng Des Sel; 2006 May; 19(5):231-44. PubMed ID: 16549402
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic advances in rheumatology with the use of recombinant proteins.
    Rothe A; Power BE; Hudson PJ
    Nat Clin Pract Rheumatol; 2008 Nov; 4(11):605-14. PubMed ID: 18813220
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The promise and pitfalls of monoclonal antibody therapeutics.
    Berkower I
    Curr Opin Biotechnol; 1996 Dec; 7(6):622-8. PubMed ID: 8939645
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro-engineered non-antibody protein therapeutics.
    Simeon R; Chen Z
    Protein Cell; 2018 Jan; 9(1):3-14. PubMed ID: 28271446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibody engineering and modification technologies.
    Filpula D
    Biomol Eng; 2007 Jun; 24(2):201-15. PubMed ID: 17466589
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-immunoglobulin based protein scaffolds.
    Löfblom J; Frejd FY; Ståhl S
    Curr Opin Biotechnol; 2011 Dec; 22(6):843-8. PubMed ID: 21726995
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Engineered antibody variable and constant domains as therapeutic candidates.
    Gong R; Xiao G
    Pharm Pat Anal; 2013 Sep; 2(5):637-46. PubMed ID: 24237171
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Manufacturing of recombinant therapeutic proteins in microbial systems.
    Graumann K; Premstaller A
    Biotechnol J; 2006 Feb; 1(2):164-86. PubMed ID: 16892246
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Artificial, non-antibody binding proteins for pharmaceutical and industrial applications.
    Hey T; Fiedler E; Rudolph R; Fiedler M
    Trends Biotechnol; 2005 Oct; 23(10):514-22. PubMed ID: 16054718
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Computational design gains momentum in enzyme catalysis engineering.
    Wijma HJ; Janssen DB
    FEBS J; 2013 Jul; 280(13):2948-60. PubMed ID: 23647554
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Engineered affinity proteins--generation and applications.
    Grönwall C; Ståhl S
    J Biotechnol; 2009 Mar; 140(3-4):254-69. PubMed ID: 19428722
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Directed evolution of proteins for increased stability and expression using yeast display.
    Traxlmayr MW; Obinger C
    Arch Biochem Biophys; 2012 Oct; 526(2):174-80. PubMed ID: 22575387
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design and generation of DVD-Ig™ molecules for dual-specific targeting.
    DiGiammarino E; Ghayur T; Liu J
    Methods Mol Biol; 2012; 899():145-56. PubMed ID: 22735951
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antigen generation and display in therapeutic antibody drug discovery -- a neglected but critical player.
    Ebersbach H; Geisse S
    Biotechnol J; 2012 Dec; 7(12):1433-43. PubMed ID: 23139179
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Validation of a stable recombinant antibodies repertoire for the direct selection of functional intracellular reagents.
    Villani ME; Di Carli M; Donini M; Traversini G; Lico C; Franconi R; Benvenuto E; Desiderio A
    J Immunol Methods; 2008 Jan; 329(1-2):11-20. PubMed ID: 17980894
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.